Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-26
2007-06-26
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235500, C514S326000, C514S343000, C514S422000, C544S141000, C548S518000, C548S527000, C548S530000, C548S578000, C548S950000, C546S207000, C546S208000
Reexamination Certificate
active
10561328
ABSTRACT:
The invention relates to compounds of formula (I):wherein substituents are as defined.
REFERENCES:
patent: 5731315 (1998-03-01), Ewing et al.
patent: 5958918 (1999-09-01), Choi-Sledeski et al.
patent: 6034093 (2000-03-01), Ewing et al.
patent: 6348600 (2002-02-01), Ono et al.
patent: 2002/0183324 (2002-12-01), Jacobson et al.
patent: 92/10476 (1992-06-01), None
patent: 97/43257 (1997-11-01), None
patent: 98/24784 (1998-06-01), None
patent: 2002/002519 (2002-01-01), None
patent: 2002/032897 (2002-04-01), None
patent: 2002/080853 (2002-10-01), None
patent: 03/043981 (2003-05-01), None
patent: 03/053925 (2003-07-01), None
Borthwick Alan David
Harling John David
Irving Wendy Rebecca
Kleanthous Savvas
Watson Nigel Stephen
Cheng Karen
Fox Jennifer L.
Glaxo Group Limited
Saeed Kamal
LandOfFree
3-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3808511